Press Release: State aid: the Commission clears 23 million EUR R&D aid to Novartis Italy for faster access to innovative vaccines in developing countries

The European Commission has concluded that €23 million public funding, which Italy intends to grant to Novartis Vaccines & Diagnostics S.r.l. (NV&D) for the research and development of innovative vaccines, is in line with EU state aid rules, in particular because it tackles a genuine market failure and stimulates research in the EU. The project aims at ensuring that developing countries gain quicker access to such innovative products at affordable prices.